Is SSPGX or JNJ a better dividend investment in 2026?

SSPGX currently yields 384.62% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: SSPGX offers higher current income.

What is the dividend yield difference between SSPGX and JNJ?

SSPGX has a forward dividend yield of 384.62% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 381.26 percentage points.

Home › Compare › SSPGX vs JNJ

SSPGX vs JNJ: Dividend Comparison 2026

SSPGX yields 384.62% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SSPGX wins by $8595.90M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SSPGX

● Live price

384.62%

Share price

$0.52

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8595.92M

Annual income

$5,687,167,359.75

Full SSPGX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SSPGX vs JNJ

📍 SSPGX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SSPGX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SSPGX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SSPGX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SSPGX

Annual income on $10K today (after 15% tax)

$32,692.31/yr

After 10yr DRIP, annual income (after tax)

$4,834,092,255.79/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, SSPGX beats the other by $4,834,091,552.17/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SSPGX + JNJ for your $10,000?

SSPGX: 50%JNJ: 50%

100% JNJ50/50100% SSPGX

Portfolio after 10yr

$4297.97M

Annual income

$2,843,584,093.77/yr

Blended yield

66.16%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SSPGX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SSPGX buys

JNJ buys

No recent congressional trades found for SSPGX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSSPGXJNJ

Forward yield	384.62% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$8595.92M ✓	$20.0K
Annual income after 10y	$5,687,167,359.75 ✓	$827.78
Total dividends collected	$8325.35M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SSPGX vs JNJ ($10,000, DRIP)

Year	SSPGX Portfolio	SSPGX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$49,162	$38,461.54	$10,676	$355.77	+$38.5K → SSPGX
2	$229,316	$176,712.93	$11,407	$389.39	+$217.9K → SSPGX
3	$1,015,727	$770,358.78	$12,198	$426.53	+$1.00M → SSPGX
4	$4,275,810	$3,188,982.79	$13,056	$467.62	+$4.26M → SSPGX
5	$17,121,253	$12,546,135.48	$13,987	$513.12	+$17.11M → SSPGX
6	$65,270,573	$46,950,832.41	$14,998	$563.56	+$65.26M → SSPGX
7	$237,118,507	$167,278,994.25	$16,098	$619.52	+$237.10M → SSPGX
8	$821,660,991	$567,944,188.45	$17,295	$681.69	+$821.64M → SSPGX
9	$2,718,462,559	$1,839,285,298.29	$18,599	$750.82	+$2718.44M → SSPGX
10	$8,595,922,297	$5,687,167,359.75	$20,022	$827.78	+$8595.90M → SSPGX

SSPGX vs JNJ: Complete Analysis 2026

SSPGX — Stock

The fund invests at least 80% of its net assets in equity securities, such as common and preferred stocks. It invests primarily in a limited number of large and medium sized companies (meaning companies with market capitalizations of $2 billion or more) that the fund's investment adviser, believes have above-average growth histories and/or growth potential. The fund also may invest up to 25% of its total assets in foreign securities and up to 20% of its net assets (plus any borrowings for investment purposes) in debt securities. It is non-diversified.

Full SSPGX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SSPGX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SSPGX vs SCHD SSPGX vs JEPI SSPGX vs O SSPGX vs KO SSPGX vs MAIN SSPGX vs ABBV SSPGX vs MRK SSPGX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.